 | Up a level |
Journal Article
Kuster, Simon, Jordan, Suzana 
ORCID: 0000-0002-8114-8239, Elhai, Muriel ORCID: 0000-0001-8627-5758, Held, Ulrike ORCID: 0000-0003-3105-5840, Steigmiller, Klaus, Bruni, Cosimo, Cacciapaglia, Fabio, Vettori, Serena, Siegert, Elise ORCID: 0000-0002-9594-0446, Rednic, Simona, Codullo, Veronica, Airo, Paolo, Braun-Moscovici, Yolanda, Hunzelmann, Nicolas, Salvador, Maria Joao, Riccieri, Valeria, Gheorghiu, Ana-Maria, Sancho, Juan Jose Alegre, Romanowska-Prochnicka, Katarzyna, Castellvi, Ivan, Koetter, Ina, Truchetet, Marie-Elise, Lopez-Longo, Fj, Novikov, Pavel, I, Giollo, Alessandro ORCID: 0000-0001-9355-7673, Shirai, Yuichiro, Belloli, Laura, Zanatta, Elisabetta, Hachulla, Eric, Smith, Vanessa, Denton, Chris, Ionescu, Ruxandra M., Schmeiser, Tim, Distler, Joerg H. W., Gabrielli, Armando, Hoffmann-Vold, Anna-Maria, Kuwana, Masataka, Allanore, Yannick and Distler, Oliver
(2022).
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.
RMD Open, 8 (2).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2056-5933